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Summary.-Treatment of BALB/c mice with radioactive isotopes ofthe bone-seeking
element strontium reduces the percentage of specific NK-cell cytotoxicity to only
2-6°,, compared with 13.6% for normal BALB/c and 36.3°, for athymic (nude)
BALB/c. The syngeneic plasmacytoma NS-1 was used as target in a 4h in vitro
NK-cell microassay.
Marrow cellularity in treated mice is reduced to 12-50/o of controls, but haemo-
poietic and stem-cell functions are taken over by the spleen and the peripheral blood
picture remains relatively normal. Allogeneic (H-2k) tumour transplants are rejected
normally with good anti-H-2k alloantibody response. Haemopoietic and T- and
B-cell functions are therefore substantially intact, and the defect seems confined to
NK cells.
In vivo, after s.c. inoculation of 106 NS-1 cells, 8/12 controls grew a solid tumour
after a mean delay of 30-5 + 1-25 (s.e.) days, whereas 5/6 90Sr-treated mice grew the
tumours after a delay of only 10-5 + 19 days. This markedly reduced delay in the
90Sr-treated mice lends support to suggestions that NK cells play an important role
in resisting the establishment of tumour foci (i.e. in antitumour surveillance). Mice
treated with 90Sr could be useful in evaluating the in vivo role of NK cells.
NATURAL ANTI-TUMOUR CYTOTOXICITY
shown by lymphoid cell preparations ob-
tained from animals previously unexposed
to the tumour has attracted increasing
interest over the last few years. The
effector cell involved, the Natural Killer
(NK) cell, isnon-phagocytic, non-adherent,
lacks the features typical of T or B cells,
and in man is morphologically a large
granular lymphocyte. Surface receptors
for the Fe portion of IgG are demon-
strable, and specific differentiation allo-
antigens have recently been described
(Kiessling, 1976; Herberman et al., 1979;
Saksela et al., 1979; Clark & Harmon,
1980).
Marked differences in in vitro NK
activity occur among inbred mouse strains,
and the fact that these differences corre-
late well with the capacity in vivo to resist
the establishment and growth of tumour
inocula has been the basis for suggestions
that NK cells play a role in antitumour
surveillance (Kiessling & Haller, 1978).
Particularly high in vitro NK activity, and
correspondingly increased resistance to the
establishment of some transplanted
tumours, has been noted in athymic
(nude) mice (Warner et al., 1977). Nude
mice also show very low incidence of
spontaneous tumours, which points to the
relative unimportance of thymus-derived
cells in anti-tumour surveillance (Rygaard
& Povlsen, 1976).
Animal models deficient in NK activity
would be useful in further evaluating the
role of these cells in vivo. One such model,
the beige mouse, has recently been des-
cribed. This mutant shows, inter alia, a
marked NK-cell defect and increased
susceptibility to the establishment and
metastasis of transplanted tumours (Tal-
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madge et al., 1980; Karre et al., 1980).
In vitro NK activity is also reported to be
diminished after neonatal exposure to
diethylstilboestrol in certain strains of
mice, including BALB/c (Kalland, 1980).
Treatment with radioactive isotopes of
the bone-seeking element strontium has
previously been shown to produce selective
loss of in vitro NK activity (Kumar et al.,
1979; Bennett et al., 1976). We report here
experiments using BALB/c mice treated
with 90Sr to study in vitro and in vivo
changes in response to a syngeneic plasma-
cytoma line.
MATERIALS AND METHODS
BALB/c and CBA/J mice were bred in the
departmental animal house from breeding
nuclei supplied by the Laboratory Animal
Centre, Carshalton, Surrey. Nude mice were
produced in the departmental animal house
on a BALB/c background; more than 10 in-
cross, back-cross, cycles having been com-
pleted. Female animals only were used in all
experiments. Both nude and normal animals
were maintained in clean but conventional
animal-house conditions.
51Cr as sodium chromate in saline solution
and 90Sr as the nitrate were obtained from
the Radiochemical Centre, Amersham, Eng-
land.
The non-secreting subline NS-1 of the
BALB/c plasmacytoma P3, used in the de-
partment for generating monoclonal antibody
clones, was used as target in the in vitro
cytotoxicity assays, and was inoculated s.c.
in the in vivo growth experiments. The cell
line was maintained in RPMI-1640 medium
with 10% foetal calf serum.
BALB/c mice, aged 4-5 weeks, each re-
ceived 3 weekly i.p. injections of 15 ,uCi
90Sr, delivered in 0-2 ml saline, giving a total
of 45 ,uCi per mouse.
Effector cells for in vitro NK-cell assays
were obtained from treated mice 4 weeks after
the final 90Sr injection (at age 10-11 weeks),
and from similarly aged untreated BALB/c
mice. Nude donors were aged 8-10 weeks.
Spleen cells free of macrophages were pre-
pared from 3 spleens per group by the follow-
ing procedure: Spleens were cut into fine
pieces with scissors and gently squeezed with
broad-bladed forceps. The cells released were
washed once, pelleted and red cells were
lysed by distilled-water shock. Lymphocytes
were washed once in Eagle's minimum essen-
tial medium (MEM) and resuspended to
2-5 x 106 cells/ml in the same medium with
5% foetal calf serum. Ten-ml aliquots of
this suspension were incubated in 100mm-
diameter culture-grade plastic Petri dishes at
37TC for 30 min in 5% CO2 in air. At the end
of the incubation the Petri dishes were
rocked gently several times and the non-
adherent cell suspension was aspirated,
washed once and resuspended in the same
medium to give appropriate cell concentra-
tions for the effector:target ratios used in the
NK assay. The suspensions contained <2%
macrophages when tested with a C'-coated
yeast-uptake assay. (Shaala et al., 1979).
Labelling of target cells and cytotoxicity
testing.-A 51Cr-release microcytotoxicity
assay was used (Brunner et al., 1976). Briefly,
100 ,uCi of 51Cr (sp. act. 100-350 /tCi/tLg) in
0-1-012 ml of saline were added to a washed
and pelleted deposit of 2 x 106 NS-1 cells.
The volume was made up to 0-4 ml with
MEM with 5% FCS, and the cells were re-
suspended. The mixture was incubated in
5% CO2 in air for 30 min at 37TC, gently
washed x4 and finally resuspended in the
same medium at 5 x 104/ml. Cytotoxicity
testing was done in round-bottomed micro-
titre trays using 0 1 ml of51Cr-labelled target-
cell suspension (5 x 103/well) and an equal
volume of effector-cell suspension at appro-
priate cell concentrations to give the effector:
target ratios shown in Fig. 1. Total release
was obtained by 10% saponin lysis of 5 x 103
labelled cells. Spontaneous-release wells in-
cluded 105 unlabelled NS-1 cells, in addition
to 5 x 103 labelled NS-1 cells, in order to
reduce nonspecific 51Cr release (< 15%).
Plates were incubated at 37°C for 4 h in 5%
CO2 in air. Total release, spontaneous release
and tests were done in replicates of 8 wells. A
Gamma-500 set was used to measure released
51Cr. Percentage specific cytotoxicity for each
test was calculated as
Test-mean spontaneous release 100
Mean total release-mean
spontaneous release
Values in Fig. 1 represent mean+ s.e. of 8
test replicates.
In vivo growth of NS-1 tumour was ob-
served after s.c. injection (in the left lower
quadrant of the abdomen) of 106 washed
NS-1 cells in 0-2 ml of serum-free MEM.
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Injected animals were examined
visible or palpable tumour nodules
ofinjection. Observable tumours w
ovoid in shape, and 2 measuremE
the long axis and at right angles t
centre, were made with calipers
to the nearest mm. Six 90Sr-treat
weeks after treatment, i.e. 10-11 A
12 untreated BALB/c controls (san
6 BALB/c nu/nu mice (8-10 weeks
used in the in vivo tumour-grow
ment.
The H-2k lymphoma TLX-5 ws
i.p. at a dose of 4 x 103 cells/mous
the capacity for responses against
tumour grafts. The line was mair
serial ascitic passage in syngeneic
Titration of alloantibody (anti-]
by complement-mediated cytotoxi
rabbit serum absorbed with BAL
cells as complement source and C]
cytes as targets. Percentage cytotc
estimated by trypan-blue exclusio
suspensions were prepared by flus
femurs per group with MEM.
red-cell and white-cell counts weri
blood obtained by tail bleeding. Un
peritoneal cells were obtained by w
with cold MEM, and the percentag4
phages was estimated using co
coated dyed-yeast uptake (Shaalae
RESULTS AND DISCUSSIO
Radioactive isotopes of stront
ize rapidly in the metaphysea
long bones and in the axial
TABLE.-Haematological parah
90Sr-treated and normal mic
from 4 mice per group)
Parameter
measured
Treated
group
1. Peripheral-blood cell
concentrations:
Erythrocytes 9.9 x 106/mm3 9.E
Total leucocytes 6-7 x 103/mm3 11
Differential white-
cell percentages
Polymorphs 20-0%
Monocytes 7-5%
Lymphocytes 72-6%
2. Nucleated cells in
marrow washout 1-5 x 106/Femur 12
3. Yeast-ingesting cells
in peritoneal
washout 15-3%
daily for 90Sr used in our study decays to give the
at the site radioactive and similarly bone-localizing
ere usually daughter isotope yttrium 90 (90Y) and the
ents, along equilibrium mixture of 90Sr+90Y emits
to it at the radiation which severely damages the measuring marrow (Spiers, 1968). This produces
leeks old), amost complete loss of cellularity, but
ae age) and extra-medullary haemopoietic activity in
s old) were the spleen maintains peripheral-blood cell
rth experi- counts (Table). For the mixture 9OSr/90Y
the f-particle maximum range in tissue is
as injected 11-3 mm and for 89Sr-treated animals the
3e to study maximum range in tissue is 6-6 mm (both allogeneic quoted from Spiers, 1968). This means
CBAinedcby that there is also some inevitable damage
CB2k) was to the soft tissues surrounding the bone,
icity using but this is not considered to be of any
,B/c spleen importance compared to the effects in the
BA thymo- marrow. The divided dosage schedule
)xicity was builds up radioactivity gradually in the
)n. Marrow bone, allowing the spleen to take over
;hing out 4 haemopoiesis. The spleen in treated ani-
Peripheral mals is enlarged, and histologically shows
e made on extensive areas of extramedullary haemo- istimulated poiesis in the red pulp. Splenectomized amshing out mice do not survive the acute irradiation
mplement- by 90Sr (Nilsson et al., 1980).
al., 1979. The lymphoma TLX-5 is a rapidly
metastasizing CBA-derived H-2k line. I.p.
N injection of 4 x 103 cells kills all animals within 10 days in syngeneic CBA mice and
ium local- in nude mice. Two 90Sr-treated BALB/c
1 ends of mice and 4 normal control BALB/c mice
skeleton: were similarly injected and observed for
4 weeks. They remained healthy, and at
neters in the end of 4 weeks they were bled and
e. (Means anti-H-2k cytotoxic-antibody titration
showed similar titres in treated and con-
trol groups (Fig. 3). These in vivo findings
Controls indicate that T-cell and B-cell functions
are substantially intact in the 90Sr-
8X106/MM3 treated mice, and confirm similar con-
5X 103/mm3 clusions by other workers (Bennett et al.,
1976). The number of functional macro-
3100% phages, as indicated by ingestion of
9.1% complement-coated yeasts, also seems to 59.9% be comparable in treated and control
groups (Table). ,x16/Femur In vitro NK activity is almost totally
abrogated in the 90Sr-treated mice (0-
18-7% 2.6%), compared with levels of 6.4-
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FIG. 1. Loss of in, vitro NK activity after
908r treatment. 51Cr-labelled NS-1 cells at
5 x 103/well were used as targets. Values
shown are means + s.e. of 8 replicates.
[, 90Sr-treated group; 0, untreate(d con-
trol group; O, untreated nucle mice.
13.8 0 in untreated controls at theeffector:
target ratios tested (Fig. 1). Syngeneic
nude mice in the same experitnent showed
NK activities in the range 17.9-36.3%,
confirming earlier observations of high
NK activity in these mutants (Kiessling
etal., 1975).
Stern-cell functions for the generation
of T and B cells appear to be adequately
taken over by the spleen after 90Sr treat-
ment. Differentiation of NK activity,
however, seems to have an absolute re-
quirement for a marrow environment.
After radiostrontium treatment, normal
target-cell-binding lymphocytes are re-
ported to be present, but these fail to
lyse the targets, and this loss of lytic
capacity is not restored even after inter-
feron treatment (Kumar et al., 1979).
Thus, the presence of an intact marrow
environment seems to be essential for the
differentiation of the NK-cell lineage from
the target-binding stage to the fully active
killer cells.
Fig. 2 illustrates the time course of the
90Sr-treated mice
Untreated controls
10 20 30 40 50 60
tNS-1 cells Days after inoculation Experiment
106/mouse (s.c.) terminated
FIa. 2.-Time course of appearance and
(luration of subcutaneous tumours. Each
bar represents the period during whichi an
indlividual animal showed palpable sub-
cutaneous tumour. Tumour did not take in
4/12 normals and 1/6 90Sr-treated animals
(and in 5/6 nudes, not shown in chart).
The largest dimensions reached (in mm)
by the tumours in the treated group were,
from the top: 7x11, 5x5, 7x11, 14x16
and 9 x 11. The tumour which regressed in
the control groLup reached a maximum size
of 5 x 6. Progressively growing tumours all
reached sizes > 20 mm at the termination
of tlhe experiment.
appearance and duration oftumours in the
treated and control groups. The mean
delay before development of palpable
tumour in the treated group is only
105 + 1-9 (s.e.) days, and is significantly
shorter (P< 0.01 by the t test with 11
degrees of freedom) than the 305 + 1*25
days observed in controls. The tumours
failed to grow in 1 of the 6 treated mice,
4 of the 12 normal controls, and in 5 of
6 nude mice. A tumour appeared on the
27th day in the one nude mouse which
did grow the tumour. The correlation
between in vitro NK activity and the
resistance to the establishment of trans-
planted syngeneic tumours (as manifested
by longer delay and fewer "takes") lends
further support to the suggestion that NK
cells play an important role in resisting
the initial growth of tumour foci (i.e.
in anti-tumour surveillance).
We have observed in other experiments
that when large doses of plasmacytoma
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FIG. 3.-Anti-H-2k antibody titres after
rejection of CBA lymphoma in 2 90Sr-
treated mice and controls.' O, pooled serum
from 4 control mice after rejecting CBA
lymphoma; 0, 90Sr-treated Mouse I after
rejecting CBA lymphoma; 0, 90Sr-treated
Mouse II after rejecting CBA lymphoma;
*, normal BALB/c serum.
cells (107) are injected into normal mice,
rapid initial growth is often followed by
regression of the tumours. The larger
inoculum and rapid initial growth often
seems to cause eventual rejection, whereas
smaller inocula seem more likely to pro-
duce tolerance. After a successful take,
tumour regression does not seem to occur
in nude mice, indicating that this late
resistance to established tumours is
thymus-dependent. An explanation on the
above lines may account for our observa-
tion (Fig. 2) of the eventual regression of
the tumours in the 90Sr-treated group,
whereas they grew progressively in 7/8
control mice and the one nude in which
the tumour became established. Thefailure
of 90Sr-treated mice rapidly to eliminate
the tumour inoculum would, in effect,
leave this experimental group with a
larger initial load of tumour cells.
90Sr treated mice seem to offer a useful
animal model for short-term experiments
aimed at evaluating the in vivo role ofNK
cells. It is possible that the dose of 90Sr
used in our study, and the doses used in
previous studies (Bennett et al., 1976;
Kumar et al., 1979) may have been well
in excess of the minimum required for
deprivation of NK activity. Further
experimentation with lower doses of 90Sr
would be useful. In addition it would be
of great interest to examine alternative
sources of marrow irradiation for specific
NK-cell depletion, and in particular the
properties of 45Ca (Ep max = 0 25 MeV)
where the low-energy 3 radiation would
have a tissue range <1 mm, and so would
confine the cell damage more precisely
to the bone mass. It is in any event impor-
tant to develop alternative models for
studying the long-term effects of NK-cell
deprivation, such as changes in the inci-
dence of spontaneous tumours. Such
studies in 90Sr-treated mice are compro-
mised by their propensity to develop
radiation-induced malignancies of lym-
phoid or osteogenic origin (Nilsson et al.,
1980).
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